A phase II trial investigating a twice weekly administration of the oral taxane BMS-275183 in patients with NSCLC [non-small cell lung cancer]

Trial Profile

A phase II trial investigating a twice weekly administration of the oral taxane BMS-275183 in patients with NSCLC [non-small cell lung cancer]

Planning
Phase of Trial: Phase II

Latest Information Update: 15 Feb 2006

At a glance

  • Drugs BMS 275183 (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Feb 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top